GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euro-Med Laboratories Philippines Inc (PHS:EURO) » Definitions » Days Sales Outstanding

Euro-Med Laboratories Philippines (PHS:EURO) Days Sales Outstanding : 119.87 (As of Mar. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Euro-Med Laboratories Philippines Days Sales Outstanding?

Euro-Med Laboratories Philippines's average Accounts Receivable for the three months ended in Mar. 2024 was ₱1,535 Mil. Euro-Med Laboratories Philippines's Revenue for the three months ended in Mar. 2024 was ₱1,169 Mil. Hence, Euro-Med Laboratories Philippines's Days Sales Outstanding for the three months ended in Mar. 2024 was 119.87.

The historical rank and industry rank for Euro-Med Laboratories Philippines's Days Sales Outstanding or its related term are showing as below:

PHS:EURO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 105.08   Med: 133.56   Max: 156.61
Current: 109.01

During the past 13 years, Euro-Med Laboratories Philippines's highest Days Sales Outstanding was 156.61. The lowest was 105.08. And the median was 133.56.

PHS:EURO's Days Sales Outstanding is ranked worse than
78.59% of 995 companies
in the Drug Manufacturers industry
Industry Median: 71.56 vs PHS:EURO: 109.01

Euro-Med Laboratories Philippines's Days Sales Outstanding declined from Mar. 2023 (121.58) to Mar. 2024 (119.87).


Euro-Med Laboratories Philippines Days Sales Outstanding Historical Data

The historical data trend for Euro-Med Laboratories Philippines's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euro-Med Laboratories Philippines Days Sales Outstanding Chart

Euro-Med Laboratories Philippines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 109.26 156.61 145.29 119.16 105.08

Euro-Med Laboratories Philippines Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 121.58 135.25 132.68 78.85 119.87

Competitive Comparison of Euro-Med Laboratories Philippines's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Euro-Med Laboratories Philippines's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Euro-Med Laboratories Philippines's Days Sales Outstanding falls into.



Euro-Med Laboratories Philippines Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Euro-Med Laboratories Philippines's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (1439.379 + 1591.603) / 2 ) / 5263.939*365
=1515.491 / 5263.939*365
=105.08

Euro-Med Laboratories Philippines's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (1591.603 + 1479.078) / 2 ) / 1168.811*365 / 4
=1535.3405 / 1168.811*365 / 4
=119.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Euro-Med Laboratories Philippines  (PHS:EURO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Euro-Med Laboratories Philippines Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Euro-Med Laboratories Philippines's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Euro-Med Laboratories Philippines (PHS:EURO) Business Description

Traded in Other Exchanges
N/A
Address
San Marcelino Street, 1000 United Nations Avenue corner, PPL Building, 2nd floor, Manila, PHL, 1000
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small volume parenterals and other solutions. The company also manufactures sterile water for the injection, and other solutions such as ophthalmic, inhalation, irrigation and dialysis. It operates through the following segments: The Manufacturing pharmaceutical segment involves the manufacturing of pharmaceutical products. The Health and other care Service segment operates a dialysis center. Development and operation of quick-service restaurant segment include operations of the quick-service restaurant, catering, food production and other related services.

Euro-Med Laboratories Philippines (PHS:EURO) Headlines

No Headlines